HomePage | Biosensors International Ltd

Spotlight BioMimics 3D™
Biosensors Enters Into Distribution Agreement with Veryan for BioMimics 3D Stent
Biosensors International Group has announced (28 January 2015) a distribution agreement with Veryan Medical Ltd. for BioMimics 3D™, a nitinol stent with unique three-dimensional helical geometry designed for use in the superficial femoral artery. The agreement covers certain international markets, but excludes the USA and Japan.
BioMatrix NEOFLEX™
BioMatrix NeoFlex™ is the latest addition to the BioMatrix family of drug-eluting stents (DES).™
It features an enhanced catheter delivery system with a lower entry profile than its predecessor, so improving pushability, trackability and crossability. BioMatrix NeoFlex retains the same unique combination of abluminal biodegradable polymer coating, Biolimus A9™ and flexible platform which have made the BioMatrix family of DES so popular.

Spotlight BioFreedom™
Spotlight BioFreedom™ DAPT
Duration: How Low Can You Go?
An update on BioFreedom clinical trials around the world, featuring interviews with the Principal Investigators from LEADERS Free; LEADERS Free Japan; The US IDE trial; and EGO BioFreedom.
Watch the video
1 month DAPT: BioFreedom™ –
a patient-centric approach to coronary stenting.
This TCT 2014 symposium discussed potential for improving patient experienceof stenting by lowering the duration of DAPT.
First Quarter FY2016 Financial Results Webcast Monday, 3 August 2015
at 6pm Singapore time